Injectable solution of an LHRH antagonist

Details Injectable solution of an LHRH antagonist Injectable solution of an LHRH antagonist

2007-05-08

2007-05-08

Tsang, Cecilia J. (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S012200, C424S001690

Reexamination Certificate

active

10279625

ABSTRACT:
An aqueous injectable soution of an LHRH antagonist, such as Cetrorelix, in an organic, pharmaceutically acceptable acid, such as gluconic acid.

REFERENCES:
patent: 4667014 (1987-05-01), Nestor et al.
patent: 5140009 (1992-08-01), Haviv et al.
patent: 5300492 (1994-04-01), Haviv et al.
patent: 2002/0039996 (2002-04-01), Bauer et al.
patent: 2004/0110689 (2004-06-01), Garnick
patent: 0 299 402 (1989-01-01), None
patent: 0 788 799 (1997-08-01), None
patent: WO 98/25642 (1998-06-01), None
patent: WO 00/47234 (2000-08-01), None
patent: WO 01/21194 (2001-03-01), None
patent: WO 01/82265 (2001-11-01), None
patent: WO 01/87265 (2001-11-01), None

Affiliated with

Also associated with

Rating

Injectable solution of an LHRH antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Injectable solution of an LHRH antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Injectable solution of an LHRH antagonist will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3762434